We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
17 hedge funds and large institutions have $26.6M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
21% more funds holding
Funds holding: 14 → 17 (+3)
11% more capital invested
Capital invested by funds: $24M → $26.6M (+$2.61M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.19M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$683K |
| 3 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$445K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$30.1K |
| 5 |
Goldman Sachs
New York
|
+$29.6K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 2 |
Morgan Stanley
New York
|
-$66 |
